Drug intelligence / Profile preview

18F-fluoroboronophenylalanine

Development stage
Unknown
Lead developer
Stella Pharma
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

18F-fluoroboronophenylalanine ([18F]FBPA) is a radiopharmaceutical positron emission tomography (PET) tracer developed primarily as a companion diagnostic for Boron Neutron Capture Therapy (BNCT). It is a fluorine-18 labeled analog of boronophenylalanine (BPA), the boron carrier used in BNCT. The molecule is actively transported into cells via the Large Neutral Amino Acid Transporter 1 (LAT1/SLC7A5), which is frequently overexpressed in malignant tissues such as gliomas, head and neck cancers, and melanomas. By mimicking the pharmacokinetic behavior of the therapeutic agent BPA, [18F]FBPA-PET imaging allows clinicians to visualize and quantify the tumor-to-normal tissue (T/N) ratio of boron accumulation. This information is critical for identifying patients most likely to benefit from BNCT, optimizing treatment planning, and performing accurate dosimetry.

Brand names
NBB-002NBB002NBB 002
Other names
4-borono-2-[18F]fluoro-L-phenylalanine2-[18F]fluoro-4-borono-L-phenylalanine4-borono-2-18F-fluoro-L-phenylalanine
02

Targets

LAT2 (Linker for activation of T cells family member 2)SLC7A5 (Large neutral amino acid transporter small subunit 1)

Beyond the preview

Go deeper on 18F-fluoroboronophenylalanine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 18F-fluoroboronophenylalanine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call